Patent details

EP1532174 Title: ANTI-IGF-I RECEPTOR ANTIBODY

Basic Information

Publication number:
EP1532174
PCT Application Number:
PCT/US/2003/016211
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037313277
PCT Publication Number:
WO/2003/106621
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-IGF-I RECEPTOR ANTIBODY
French Title of Invention:
ANTICORPS ANTI-RECEPTEUR IGF-I
German Title of Invention:
ANTI-IGF-I-REZEPTOR-ANTIKÖRPER
SPC Number:

Dates

Filing date:
12/06/2003
Grant date:
27/04/2011
EP Publication Date:
27/04/2011
PCT Publication Date:
24/12/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/05/2005
EP B1 Publication Date:
27/04/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/06/2011
Expiration date:
12/06/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/06/2003
 
 

Name:
ImmunoGen Inc.
Address:
830 Winter Street, Waltham, MA 02451, United States (US)

Inventor

1

Name:
TAVARES Daniel, J.
Address:
United States (US)

2

Name:
DAGDIGIAN Nancy, E.
Address:
United States (US)

3

Name:
SINGH Rajeeva
Address:
United States (US)

Priority

Priority Number:
170390
Priority Date:
14/06/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;
Filing date Document type Number of pages